Abstract:
The key to change in the pharmaceutical industry is technology and new drug introductions versus exposure to generic competition. The net effect equals the critical stock selection criterion for pharmaceutical investing.
This could also be of interest:
Case Studies
                        
                             In-depth pharmaceutical competitor analysis
                            
                        
                        In-depth pharmaceutical competitor analysis                    
                
                                Catalogue: EPHMRA/ESOMAR Seminar 1985: Pharmaceutical Competitor Analysis
Author: William Hall
 
 February 27, 1985
 February 27, 1985
                            Research Papers
                        
                             Competitor analysis
                            
                        
                        Competitor analysis                     
                
                                Catalogue: EPHMRA/ESOMAR Seminar 1985: Pharmaceutical Competitor Analysis
Author: Stewart Fairbairn
 
 February 27, 1985
 February 27, 1985
                            Research Papers
                        
                             Competitor analysis by patient monitoring
                            
                        
                        Competitor analysis by patient monitoring                    
                
                                Catalogue: EPHMRA/ESOMAR Seminar 1985: Pharmaceutical Competitor Analysis
Authors: Ingrid Köpl, Gerd Bögel
Company: Marplan Forschungsgesellschaft mbH
 February 27, 1985
 February 27, 1985
                             
				